Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

LG-120907, a potent antiandrogen with reduced adverse effects

July 16, 1998

Risperidone: satellite symposia discuss impact on cognition and behavior

July 16, 1998

M-100907 improves positive and negative symptoms and is well tolerated in schizophrenics

July 15, 1998

Preliminary evidence of antidepressant effect for igmesine, a sigma ligand

July 15, 1998

Spotlight on estrone sulfatase inhibitors for treatment of breast cancer

July 14, 1998

EM-800, a more potent antiestrogen than raloxifene in preclinical studies

July 14, 1998

New evidence supports the efficacy of PKC inhibition in diabetic neuropathy

July 14, 1998

Vitamin D analogue EB-1089 acts via effects on IGF-I

July 14, 1998

Idoxifene: another SERM with clinical potential in postmenopausal disorders

July 14, 1998

Aldose reductase inhibitor from Nippon Zoki effective in rats with diabetic neuropathy

July 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...